“Benlysta emerges as a direct approach in lupus treatment. Developed by Human Genome Sciences and GlaxoSmith Kline, the drug is based on research done at the LMB and the Scripps Research Institute.” More…
New drug Benlysta in Lupus treatment
Hugh Pelham Knighted in Queen’s Birthday Honours.
Hugh Pelham, Director of the LMB, has been honoured with a knighthood in the Queen’s birthday honours for 2011. The award is for services to science. Hugh has been Director of the LMB since 2006, and a staff member since 1981. He became Head of the Cell Biology Division in 1992, and Deputy Director of […]
Jan Löwe to receive Wellcome Trust Senior Investigator Award.
Jan Löwe from the LMB’s Structural Studies Division will receive one of the Wellcome Trust’s inaugural Senior Investigator Awards, aimed at providing flexible longer-term funding to enable exceptional researchers to tackle important research questions about health and disease. The Wellcome Trust has appointed 27 Investigators – 7 New Investigators and 20 Senior Investigators – based […]
Heptares and AstraZeneca collaborate on drug development
“LMB spin-out company, Heptares Therapeutics, have entered a four-year collaboration with AstraZeneca on the development of new drugs targeting proteins.” More…
Honours for outstanding contributions to science
“LMB scientists, Sean Munro and Andrew McKenzie, have been honoured for their outstanding contributions to the advancement of medical sciences.” This article is no longer available from the source website: Cambridge First 20 May 2011
LMB scientists in Cambridge honoured
“Two MRC LMB scientists in Cambridge have received top honours. Sean Munro has been elected as a Fellow of the Royal Society, and Andrew McKenzie has been elected as a Fellow of the Academy of Medical Sciences.” More…